TUMOUR LYSIS SYNDROME

This adverse event was reported 8807 times

These drugs are most commonly taken by patients reporting TUMOUR LYSIS SYNDROME:

# Drug Count
0 RITUXIMAB 1409
1 CYCLOPHOSPHAMIDE 1264
2 CYCLOPHOSPHAMIDE FOR INJECTION 1264
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1264
4 DEXAMETHASONE 1221
5 DEXAMETHASONE 1.5 MG 1221
6 VENETOCLAX 1180
7 PREDNISONE 870
8 ALLOPURINOL 868
9 DOXORUBICIN 835
See all common drugs associated with TUMOUR LYSIS SYNDROME

TUMOUR LYSIS SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RASBURICASE 364 0.1471
1 OBINUTUZUMAB 344 0.0203
2 VENETOCLAX 1180 0.0188
3 BENDAMUSTINE HYDROCHLORIDE 148 0.0174
4 CHLORAMBUCIL 60 0.0153
5 VANCOMYCIN HYDROCHLORIDE 118 0.0141
6 AZACITIDINE 400 0.0133
7 FEBUXOSTAT TABLETS 40 MG 129 0.0124
8 BENDAMUSTINE HCL 185 0.0118
9 ETOPOSIDE 787 0.0107
See all drugs enriched for association with TUMOUR LYSIS SYNDROME